Date published: 2026-5-30

1-800-457-3801

SCBT Portrait Logo
Seach Input

SDR39U1 Inhibitors

The chemical class designated as SDR39U1 Inhibitors encompasses a diverse array of compounds that are identified based on their ability to modulate the activity of the SDR39U1 enzyme. These inhibitors are not confined to a single molecular scaffold or chemical family but are rather characterized by their functional impact on the enzyme. The primary strategy for inhibition involves the obstruction of the enzyme's active site, where the enzymatic reaction takes place. Inhibitors in this class can achieve this by mimicking the structure of the enzyme's natural substrates or cofactors, thereby preventing the legitimate substrates from accessing the catalytic site. Active site inhibitors can either be competitive, occupying the site in place of the substrate, or uncompetitive, binding only to the enzyme-substrate complex. Other inhibitors can be designed to resemble the transition state of the substrate during the enzymatic reaction, which typically allows for a high-affinity interaction, thereby leading to potent inhibition.

Beyond the active site, SDR39U1 inhibitors can also target other enzyme-specific domains, such as allosteric sites, which are regions separate from the active site that can regulate enzyme activity when bound by a ligand. Allosteric inhibitors can induce conformational changes that reduce the enzyme's activity, even without directly blocking the active site. In some cases, the enzyme function can be modulated by covalently modifying key amino acid residues within the active site, leading to irreversible inhibition. The enzymes in the SDR family, including SDR39U1, often require cofactors such as NAD(H) or NADP(H) for activity, and thus, inhibitors that resemble these cofactors can serve to prevent the proper cofactor from binding and participating in the reaction. In addition to these mechanisms, certain inhibitors can also exert their effects by modulating the expression levels of the enzyme or by interfering with the necessary post-translational modifications required for enzymatic activity. The diversity in the modes of action reflects the complexity of the enzyme's regulation and the intricate design of the inhibitors that can influence its function.

SEE ALSO...

Product NameCAS #Catalog #QUANTITYPriceCitationsRATING

Quercetin

117-39-5sc-206089
sc-206089A
sc-206089E
sc-206089C
sc-206089D
sc-206089B
100 mg
500 mg
100 g
250 g
1 kg
25 g
$11.00
$17.00
$110.00
$250.00
$936.00
$50.00
33
(2)

Quercetin, a flavonoid, has been shown to inhibit various SDR enzymes by binding to the NAD(P)+ binding site and could possibly inhibit SDR39U1 through the same mechanism.

Trichloroacetaldehyde-13C2

sc-474862
2.5 mg
$380.00
(0)

Chloral hydrate is a sedative and hypnotic drug that also inhibits alcohol dehydrogenase by competing with the substrate at the active site and could possibly inhibit SDR39U1.

Ebselen

60940-34-3sc-200740B
sc-200740
sc-200740A
1 mg
25 mg
100 mg
$33.00
$136.00
$458.00
5
(1)

Ebselen is a seleno-organic compound that acts as a mimic of glutathione peroxidase but also inhibits various dehydrogenases and could possibly inhibit SDR39U1 by targeting its active site.

Finasteride

98319-26-7sc-203954
50 mg
$105.00
3
(1)

Finasteride is a competitive inhibitor of steroid 5α-reductase, which is part of the SDR family, by mimicking the substrate's transition state, and could possibly inhibit SDR39U1 if it has a similar mechanism.

Indomethacin

53-86-1sc-200503
sc-200503A
1 g
5 g
$29.00
$38.00
18
(1)

As a nonsteroidal anti-inflammatory drug (NSAID), indomethacin inhibits cyclooxygenase, but it also inhibits aldo-keto reductases, which are related to the SDR family, and could possibly inhibit SDR39U1 through off-target effects.

Capsaicin

404-86-4sc-3577
sc-3577C
sc-3577D
sc-3577A
50 mg
250 mg
500 mg
1 g
$96.00
$160.00
$240.00
$405.00
26
(1)

Capsaicin, the active component in chili peppers, has been reported to inhibit certain reductases and could possibly inhibit SDR39U1 by binding to allosteric sites or the active site.